Future directions in the development of pemetrexed

被引：16

作者：

Calvert, H ^{[1
]}

Bunn, PA

机构：

[1] Newcastle Univ, Dept Oncol, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England

[2] Univ Colorado, Ctr Canc, Denver, CO 80262 USA

来源：

SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 02期

关键词：

D O I：

10.1053/sonc.2002.30761

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：54 / 61

页数：8

共 57 条

[1] Phase I and pharmacologic study of sequences of gemcitabine and the multitargeted antifolate agent in patients with advanced solid tumors [J].

Adjei, AA ;

Erlichman, C ;

Sloan, JA ;

Reid, JM ;

Pitot, HC ;

Goldberg, RM ;

Peethambaram, P ;

Atherton, P ;

Hanson, LJ ;

Alberts, SR ;

Jett, J .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (08) :1748-1757

[2]

Alati T, 1996, CANCER RES, V56, P2331

[3] Homocysteine and risk of cardiovascular disease [J].

Andreotti, F ;

Burzotta, F ;

Manzoli, A ;

Robinson, K .

JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2000, 9 (01) :13-21

[4] Activity of the multitargeted antifolate LY231514 in the human tumor cloning assay [J].

Britten, CD ;

Izbicka, E ;

Hilsenbeck, S ;

Lawrence, R ;

Davidson, K ;

Cerna, C ;

Gomez, L ;

Rowinsky, EK ;

Weitman, S ;

Von Hoff, DD .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 44 (02) :105-110

[5]

BUNN P, 2001, P AN M AM SOC CLIN, V20, pA76

[6] A PHASE-I EVALUATION OF THE QUINAZOLINE ANTIFOLATE THYMIDYLATE SYNTHASE INHIBITOR, N-10-PROPARGYL-5,8-DIDEAZAFOLIC ACID, CB3717 [J].

CALVERT, AH ;

ALISON, DL ;

HARLAND, SJ ;

ROBINSON, BA ;

JACKMAN, AL ;

JONES, TR ;

NEWELL, DR ;

SIDDIK, ZH ;

WILTSHAW, E ;

MCELWAIN, TJ ;

SMITH, IE ;

HARRAP, KR .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (08) :1245-1252

[7]

CALVERT AH, 2000, P AN M AM SOC CLIN, V9, pA495

[8] PHASE-II STUDY OF THE ANTIFOLATE N-10-PROPARGYL-5,8-DIDEAZAFOLIC ACID (CB-3717) IN ADVANCED BREAST-CANCER [J].

CANTWELL, BMJ ;

MACAULAY, V ;

HARRIS, AL ;

KAYE, SB ;

SMITH, IE ;

MILSTED, RAV ;

CALVERT, AH .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (04) :733-736

[9]

Caponigro F, 1999, CLIN CANCER RES, V5, P3948

[10]

CLARKE S, 1997, P AN M AM SOC CLIN, V16, P465

← 1 2 3 4 5 6 →